LTFS
SGMO

Ladenburg Thalmann Financial Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$90K Sell
10,557
-1,832
-15% -$16.8K ﹤0.01% 3106
2019
Q3 		$113K Sell
12,389
-1,800
-13% -$20.2K ﹤0.01% 2850
2019
Q2 		$151K Buy
14,189
+727
+5% +$7.73K ﹤0.01% 2672
2019
Q1 		$129K Sell
13,462
-1,467
-10% -$15K ﹤0.01% 2725
2018
Q4 		$172K Sell
14,929
-5,833
-28% -$72.5K ﹤0.01% 2341
2018
Q3 		$352K Buy
20,762
+3,650
+21% +$55.5K ﹤0.01% 1875
2018
Q2 		$325K Hold
17,112
– – ﹤0.01% 1876
2018
Q1 		$325K Sell
17,112
-2,077
-11% -$44.4K ﹤0.01% 1876
2017
Q4 		$314K Buy
19,189
+7,900
+70% +$118K ﹤0.01% 1874
2017
Q3 		$169K Buy
11,289
+549
+5% +$6.07K ﹤0.01% 2230
2017
Q2 		$94K Buy
10,740
+3,000
+39% +$19.2K ﹤0.01% 2553
2017
Q1 		$41K Buy
7,740
+940
+14% +$3.77K ﹤0.01% 3062
2016
Q4 		$21K Buy
6,800
+2,300
+51% +$8.38K ﹤0.01% 3454
2016
Q3 		$21K Hold
4,500
– – ﹤0.01% 3380
2016
Q2 		$26K Sell
4,500
-119
-3% -$758 ﹤0.01% 3162
2016
Q1 		$28K Hold
4,619
– – ﹤0.01% 3023
2015
Q4 		$42K Buy
4,619
+1,000
+28% +$7.71K ﹤0.01% 2688
2015
Q3 		$20K Hold
3,619
– – ﹤0.01% 3109
2015
Q2 		$40K Hold
3,619
– – ﹤0.01% 2747
2015
Q1 		$57K Hold
3,619
– – ﹤0.01% 2457
2014
Q4 		$55K Hold
3,619
– – ﹤0.01% 2300
2014
Q3 		$39K Hold
3,619
– – ﹤0.01% 2197
2014
Q2 		$55K Sell
3,619
-81
-2% -$1.17K ﹤0.01% 1985
2014
Q1 		$67K Hold
3,700
– – ﹤0.01% 1754
2013
Q4 		$51K Buy
3,700
+3,500
+1,750% +$40.3K ﹤0.01% 1903
2013
Q3 		$2K Hold
200
– – ﹤0.01% 3469
2013
Q2 		$2K Buy
+200
New +$1.75K ﹤0.01% 3338

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SGMO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 15% in Q4 2019, selling an estimated $16.8K and leaving 10,557 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Ladenburg Thalmann Financial Services first reported a position in SGMO in Q2 2013 and has held it in 27 quarters since. The position peaked at $352K in Q3 2018. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 10,557 shares of SANGAMO THERAPEUTICS INC worth $90K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,832 SANGAMO THERAPEUTICS INC shares in Q4 2019, an estimated $16.8K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3106 holding.
  • Ladenburg Thalmann Financial Services first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's SANGAMO THERAPEUTICS INC position peaked at $352K in Q3 2018.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.